Beta Bionics, Inc. (NASDAQ: BBNX) reported Q2 EPS of ($0.53), $0.19 worse than the analyst estimate of ($0.34). Revenue for the quarter came in at $32 million.

For earnings history and earnings-related data on Beta Bionics, Inc. (BBNX) click here.